Lysophosphatidylcholine 16:0 mediates chronic joint pain associated to rheumatic diseases through acid-sensing ion channel 3 - Archive ouverte HAL
Article Dans Une Revue Pain Année : 2022

Lysophosphatidylcholine 16:0 mediates chronic joint pain associated to rheumatic diseases through acid-sensing ion channel 3

Florian Jacquot
  • Fonction : Auteur
Julie Barbier
Lauriane Delay
Agathe Bayle
  • Fonction : Auteur
Youssef Aissouni
  • Fonction : Auteur
David Barriere
  • Fonction : Auteur
Kim Kultima
  • Fonction : Auteur
Eva Freyhult
  • Fonction : Auteur
Anders Hugo
  • Fonction : Auteur
Véronique Breuil
Fabien Marchand
  • Fonction : Auteur

Résumé

Rheumatic diseases are often associated to debilitating chronic pain, which remains difficult to treat and requires new therapeutic strategies. We had previously identified lysophosphatidylcholine (LPC) in the synovial fluids from few patients and shown its effect as a positive modulator of acid-sensing ion channel 3 (ASIC3) able to induce acute cutaneous pain in rodents. However, the possible involvement of LPC in chronic joint pain remained completely unknown. Here, we show, from 2 independent cohorts of patients with painful rheumatic diseases, that the synovial fluid levels of LPC are significantly elevated, especially the LPC16:0 species, compared with postmortem control subjects. Moreover, LPC16:0 levels correlated with pain outcomes in a cohort of osteoarthritis patients. However, LPC16:0 do not appear to be the hallmark of a particular joint disease because similar levels are found in the synovial fluids of a second cohort of patients with various rheumatic diseases. The mechanism of action was next explored by developing a pathology-derived rodent model. Intra-articular injections of LPC16:0 is a triggering factor of chronic joint pain in both male and female mice, ultimately leading to persistent pain and anxiety-like behaviors. All these effects are dependent on ASIC3 channels, which drive sufficient peripheral inputs to generate spinal sensitization processes. This study brings evidences from mouse and human supporting a role for LPC16:0 via ASIC3 channels in chronic pain arising from joints, with potential implications for pain management in osteoarthritis and possibly across other rheumatic diseases.
Fichier principal
Vignette du fichier
Jacquot et al_PAIN 2022.pdf (1.67 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-03855419 , version 1 (16-11-2022)

Licence

Identifiants

Citer

Florian Jacquot, Spiro Khoury, Bonnie Labrum, Kévin Delanoe, Ludivine Pidoux, et al.. Lysophosphatidylcholine 16:0 mediates chronic joint pain associated to rheumatic diseases through acid-sensing ion channel 3. Pain, 2022, 163 (10), pp.1999-2013. ⟨10.1097/j.pain.0000000000002596⟩. ⟨hal-03855419⟩
80 Consultations
113 Téléchargements

Altmetric

Partager

More